Predictive performance of PAMG‐1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study
- 26 March 2018
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 51 (5), 644-649
- https://doi.org/10.1002/uog.18892
Abstract
To assess the performance of the PAMG-1 and fFN tests using real-world data for the prediction of spontaneous preterm delivery (sPTD) in patients presenting to an emergency obstetrical unit with threatened preterm labour (PTL) by conducting a retrospective audit of patient medical records over two different one-year time periods during which either fFN or PAMG-1 was used as the standard of care biochemical test. A retrospective cohort study chart review of women with threatened PTL electronic medical records (EMR) from a Level III maternity hospital was conducted for two periods of one year each: (1) the “Baseline” time period, during which the qualitative fFN test with a cutoff of 50 ng/ml was used as standard of care biochemical test for the risk assessment of preterm delivery, and (2) the “Comparative” time period, during which the PAMG-1 test with a cutoff of 1 ng/mL was used as the standard of care biomarker test. Patients with singleton gestations between 24+0 to 34+6 weeks of gestation with symptoms of early preterm labour, clinically intact membranes, and cervical dilation 4 times more reliable than a positive fFN test in predicting imminent sPTD. Fewer positive biomarker test results that are more reliable is associated with a reduction in unnecessary admissions, avoidable treatments, and preventable use of hospital resources.This publication has 10 references indexed in Scilit:
- Preterm Labor and Birth Management: Recommendations from the European Association of Perinatal MedicineThe Journal of Maternal-Fetal & Neonatal Medicine, 2017
- Fetal fibronectin testing in threatened preterm labor: time to stopAmerican Journal of Obstetrics and Gynecology, 2016
- Practice Bulletin No. 171: Management of Preterm LaborObstetrics & Gynecology, 2016
- OP11.04: Comparison of the fetal fibronectin (Rapid fFN) and placental alpha microglobulin‐1 (PartoSure) tests for predicting imminent spontaneous preterm birthUltrasound in Obstetrics & Gynecology, 2016
- Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trialsAmerican Journal of Obstetrics and Gynecology, 2016
- Menace d’accouchement prématuré : reproductibilité du test de détection de la PAMG-1 avant, puis après toucher vaginal et cervicométrieGynécologie Obstétrique & Fertilité, 2015
- Cervical phosphorylated insulin-like growth factor binding protein-1 test for the prediction of preterm birth: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2015
- Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm laborjpme, 2015
- Confidence intervals for predictive values with an emphasis to case–control studiesStatistics in Medicine, 2007
- ACOG Practice Bulletin: No. 43, May 2003. Management of Preterm LaborInternational Journal of Gynecology & Obstetrics, 2003